Create Wellness Secures $20M Series B Funding

Create Wellness, a company dedicated to redefining the creatine market, has announced it has secured $20.0 million in new funding from investors.

The company's core mission is to make strength accessible, convenient, and enjoyable for everyone, irrespective of gender, athletic background, or age.

This vision began with the introduction of the industry’s first creatine monohydrate gummy and has since grown into a broader movement aimed at bringing the benefits of creatine to a mass audience.

Founded in 2022 by husband-and-wife team Dan and Sienna McCormick, Create Wellness distinguishes itself through a commitment to quality and innovation within the creatine space.

The company achieves this by meticulously sourcing world-class ingredients, fostering partnerships with leading scientists and researchers, and cultivating a best-in-class team.

This comprehensive approach is fundamental to Create Wellness's strategy of setting new industry standards for creatine products and consumer experience.

This substantial capital infusion marks a significant milestone for Create Wellness, providing crucial resources to advance its strategic objectives. The company plans to deploy the $20.

0 million to accelerate its growth initiatives, which include expanding its product development pipeline and scaling its market reach to serve more consumers.

This investment is poised to significantly bolster Create Wellness in its bold vision to make the world 10% stronger by democratizing access to effective strength solutions.

The successful completion of this funding round underscores investor confidence in Create Wellness's innovative approach and its considerable market potential within the wellness sector.

With this new capital, the company is strategically positioned to further solidify its leadership in the creatine market and continue its expansion efforts, driving forward its mission to enhance well-being and strength for a diverse global consumer base.